Evidence map›Paper›PMID 26301305›Full record

ArticleJournal of biomedical nanotechnology2015

Surface Functionalization of Chemically Reduced Graphene Oxide for Targeted Photodynamic Therapy.

Peng Huang, Shouju Wang, Xiansong Wang, Guangxia Shen, Jing Lin, Zhe Wang, Shouwu Guo, Daxiang Cui, Min Yang, Xiaoyuan Chen

Open access · greenAbstract read
In one paragraph

Article in Journal of biomedical nanotechnology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Graphene-based nanomaterials for bioimaging.Advanced drug delivery reviews · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Peng Huang
Shouju Wang
Xiansong Wang
Guangxia Shen
Jing Lin
Zhe Wang
Shouwu Guo
Daxiang Cui
Min Yang
Xiaoyuan Chen
Shanghai Jiao Tong University · CNNational Institutes of Health · USNational Institute of Biomedical Imaging and Bioengineering · US

Funding

Laboratory of Molecular Imaging and NanomedicineZIAEB000073 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI CHEN, XIAOYUAN · 2010 to 2020
$32.8M
Intramural NIH HHS Z99 EB999999Intramural NIH HHS ZIA EB000073
6 · The paper itself

Abstract

In this study, using chemically reduced graphene oxide (GO) as a model nanocarbon, we successfully developed a facile surface-functionalization strategy of nanocarbons to allow both biocompatibility and receptor targeted drug delivery. Polyvinylpyrrolidone (PVP) coating improves aqueous dispersibility and biocompatibility of GO, and provides anchoring sites for ACDCRGDCFCG peptide (RGD4C). Aromatic photosensitizer chlorin e6 (Ce6) can be effectively loaded into the rGO-PVP-RGD system via hydrophobic interactions and π-π stacking. The nanodelivery system can significantly increase the accumulation of Ce6 in tumor cells and lead to an improved photodynamic therapy (PDT) efficacy as compared to Ce6 alone. The facile surface functionalization strategy can be applied to other nanomaterials such as carbon nanotubes, and inorganic nanomaterials.

Indexed as

Cell Line, TumorChlorophyllidesDiffusionGraphiteHumansNanocapsulesOxidation-ReductionOxidesParticle SizePhotochemotherapyPhotosensitizing AgentsPorphyrinsPovidoneStomach NeoplasmsTreatment OutcomeChlorophyllidesGraphiteNanocapsulesOxidesPhotosensitizing AgentsphytochlorinPorphyrinsPovidone

Identifiers

PMID26301305
PMCPMC5218590
OpenAlexW2049581270

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.